Redpoint Investment Management Pty LTD Seagen Inc. Transaction History

Redpoint Investment Management Pty LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	BUY	$119.61 - $157.85 $353,567 - $466,604	2,956 New	2,956 $426,000
Q4 2021 Jan 19, 2022	SELL	$142.57 - $190.86 $370,682 - $496,236	-2,600 Closed	0 $0
Q1 2021 Apr 13, 2021	BUY	$137.51 - $190.8 $357,526 - $496,080	2,600 New	2,600 $361,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Redpoint Investment Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Redpoint Investment Management Pty LTD with notifications on news.